Bank Of New York Mellon Corp Mirati Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $6.97 Million - $16.7 Million	168,956 New	168,956 $7.66 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $27.8 Million - $40.5 Million	-467,090 Reduced 72.72%	175,203 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $19 Million - $42.9 Million	484,014 Added 305.8%	642,293 $43.1 Million
Q1 2022 May 11, 2022	SELL	$75.82 - $150.97 $758,275 - $1.51 Million	-10,001 Reduced 5.94%	158,279 $13 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $1.04 Million - $1.5 Million	7,886 Added 4.92%	168,280 $24.7 Million
Q3 2021 Nov 12, 2021	SELL	$132.13 - $177.45 $2.92 Million - $3.93 Million	-22,120 Reduced 12.12%	160,394 $28.4 Million
Q2 2021 Aug 11, 2021	BUY	$144.0 - $179.73 $3.31 Million - $4.14 Million	23,020 Added 14.43%	182,514 $29.5 Million
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $5.41 Million - $7.55 Million	-34,052 Reduced 17.59%	159,494 $27.3 Million
Q4 2020 Feb 09, 2021	BUY	$162.05 - $240.27 $6.12 Million - $9.08 Million	37,787 Added 24.26%	193,546 $42.5 Million
Q3 2020 Nov 12, 2020	BUY	$113.26 - $167.27 $810,828 - $1.2 Million	7,159 Added 4.82%	155,759 $25.9 Million
Q2 2020 Aug 12, 2020	BUY	$72.01 - $120.39 $1.76 Million - $2.94 Million	24,393 Added 19.64%	148,600 $17 Million
Q1 2020 May 06, 2020	SELL	$69.78 - $116.21 $10,885 - $18,128	-156 Reduced 0.13%	124,207 $9.55 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $408,072 - $743,135	5,767 Added 4.86%	124,363 $16 Million
Q3 2019 Nov 07, 2019	SELL	$77.91 - $109.6 $595,699 - $838,001	-7,646 Reduced 6.06%	118,596 $9.24 Million
Q2 2019 Aug 12, 2019	BUY	$59.49 - $104.71 $840,117 - $1.48 Million	14,122 Added 12.6%	126,242 $13 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $674,829 - $1.22 Million	15,460 Added 15.99%	112,120 $8.22 Million
Q4 2018 Feb 11, 2019	SELL	$32.0 - $47.43 $340,992 - $505,414	-10,656 Reduced 9.93%	96,660 $4.1 Million
Q3 2018 Nov 09, 2018	SELL	$47.1 - $62.7 $132,916 - $176,939	-2,822 Reduced 2.56%	107,316 $0
Q2 2018 Aug 06, 2018	BUY	$26.05 - $52.4 $2.23 Million - $4.49 Million	85,595 Added 348.76%	110,138 $5.43 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $117,768 - $239,302	6,847 Added 38.69%	24,543 $753,000
Q4 2017 Feb 09, 2018	BUY	$12.65 - $19.0 $223,854 - $336,224	17,696	17,696 $323,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account